Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03560310 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome

Study acronym: TACSI
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 2203 to 2201
    • Primary completion date changed from estimate of Mar 15, 2025 to Mar 13, 2025
    v9
  2. Trial status: Recruiting to Active, Not Recruitingv8 Show 5 more changesShow less
    • Enrollment target: estimated 2200 to confirmed 2203
    • Primary completion date: Jun 1, 2025 to Mar 15, 2025
    • Study completion date: Jun 2031 to Feb 15, 2035
    • Site details revised at 22 of 22 sites
    • Collaborators revised (2)
  3. Primary completion date: Jun 2022 to Jun 1, 2025
    • Site details revised at 5 of 22 sites
    v7
  4. Primary completion date: Jun 2021 to Jun 2022
    • Site details revised at 5 of 22 sites
    v6
  5. Study sites: 8 to 22v5
Show 3 earlier versionsHide 3 earlier versions
  1. Site details revised at 2 of 8 sitesv4
  2. Study sites: 1 to 8
    • Interventions: ASA 75-160 mg daily (Drug), Ticagrelor 90mg twice daily and ASA 75 mg daily (Drug) to ASA 75-160 mg daily (Drug), Ticagrelor 90mg twice daily and ASA 75-100 mg daily (Drug)
    • Eligibility criteria expanded, about 17 words
    • Study description revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2018 to Jun 29, 2018
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is a Randomised Registry-based Clinical Trial (RRCT) to assess whether dual antiplatelet therapy with ticagrelor and ASA compared to ASA alone improves outcome after isolated CABG in patients with acute coronary syndrome.
Trial Details
NCT Number NCT03560310
Lead Sponsor Vastra Gotaland Region
Collaborators: Gothia Forum - Center for Clinical Trial, Göteborg University
Conditions
(from sponsor)		 Acute Coronary Syndrome
Related terms Acute Coronary Syndrome
Enrollment 2,201 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov